Synopsis: The allotment for the Gaudium IVF & Women Health IPO is scheduled for finalization today, February 25, 2026. Following a solid 7.27x overall subscription, investors can now verify their application status online via the registrar’s portal or stock exchange websites.
Gaudium IVF IPO Allotment
Gaudium IVF and Women Health Limited’s ₹165 crore initial public offering (IPO) concluded its bidding process on February 24 with healthy interest across all categories.
As per the official timeline, the Basis of Gaudium IVF IPO Allotment is being finalized today. Successful bidders will see shares credited to their demat accounts by February 26, while unsuccessful applicants will receive their refunds starting late today.
Where to Check Gaudium IVF IPO Allotment Status
Investors can check their allotment status using three primary official channels.
You will need your PAN Number, Application Number, or DP ID.
1. Via Registrar (Bigshare Services Pvt Ltd)
Bigshare Services is the official registrar for this IPO. This is typically the fastest way to get your results.
- Step 1: Visit the Bigshare IPO Status Page.
- Step 2: Select “Gaudium IVF & Women Health Limited” from the company dropdown menu.
- Step 3: Choose between Application Number, Beneficiary ID, or PAN.
- Step 4: Enter the details and the Captcha, then click “Search.”
2. Via BSE (Bombay Stock Exchange)
- Step 1: Go to the BSE IPO Status Page.
- Step 2: Select “Equity” as the Issue Type.
- Step 3: Select the company name from the dropdown.
- Step 4: Enter your Application Number and PAN Number. Click “Search.”
Allotment Status: Click Here
Final Subscription Recap
The IPO saw an overall subscription of 7.27 times. The demand was notably high in the NII and Retail segments:
- Retail Individual Investors (RII): Subscribed 7.60 times.
- Non-Institutional Investors (NII): Subscribed 14.05 times (Highest demand).
- Qualified Institutional Buyers (QIB): Subscribed 1.62 times.
GMP and Listing Outlook
As of today, February 25, the Grey Market Premium (GMP) for Gaudium IVF has turned muted, hovering around ₹0 to ₹5. This suggests a flat to marginal listing gain over the issue price of ₹79.
Analysts say the first-mover advantage in the IVF sector supports long-term growth. However, the 25.3x P/E valuation and a pending ₹31 crore tax dispute have kept grey market sentiment cautious.
The shares are tentatively scheduled to debut on the NSE and BSE on Friday, February 27, 2026.
Disclaimer: The views expressed are for informational purposes only and do not constitute financial advice. Investing in stocks and IPOs involves significant risk.forgeup.in is not liable for any financial losses. Always consult a certified investment advisor before making any decisions.